Utility of Green Chemistry for Sustainable Fluorescence Derivatization Approach for Spectrofluorimetric Quantification of Pemetrexed as Antineoplastic Drug in Pharmaceutical Formulation and Spiked Human Plasma.
Hesham SalemHoda MadianSoheir EmadMaha HussienDina Z MazenPublished in: Journal of fluorescence (2024)
Pemetrexed is a chemotherapeutic medicine, under the trade name Alimta. Malignant pleural mesothelioma patients. Its application in lung cancer has been studied. Here in, a second spectrofluorimetric method was advanced for quantifying of Pemetrexed in pharmaceutical formulation and spiked human plasma. That method depends on fluorescence derivatization of Pemetrexed with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) at 75 °C in a (pH 9) of borate buffer to produce a fluorescent derivative which can be detected at 520 nm afterwards excitation at 460 nm. The method has been validated using ICH criteria, and it demonstrated linearity in a range of 2-120 ngmL-1. The proposed method was applied precisely and accurately for quantifying Pemetrexed within pharmaceutical formulation and spiking human plasma without any interferences. Moreover, the method's sustainability was evaluated and compared to the published method using two greenness assessment tools termed analytical eco-scale and Analytical GREENness (AGREE). That findings suggest that the method is more sustainable than the published method.
Keyphrases
- small cell lung cancer
- advanced non small cell lung cancer
- end stage renal disease
- drug delivery
- emergency department
- ms ms
- photodynamic therapy
- chronic kidney disease
- single molecule
- high resolution
- ejection fraction
- escherichia coli
- peritoneal dialysis
- pseudomonas aeruginosa
- cystic fibrosis
- quantum dots
- epidermal growth factor receptor
- drug resistant
- klebsiella pneumoniae
- drug induced
- fluorescent probe
- tandem mass spectrometry
- gas chromatography
- life cycle